摘要：SummaryInvasion and proliferation are defining phenotypes of cancer, and in glioblastoma blocking one stimulates the other, implying that effective therapy must inhibit both, ideally through a single target that is also dispensable for normal tissue function. The molecular motor myosin 10 meets these criteria. Myosin 10 knockout mice can survive to adulthood, implying that normal cells can compensate for its loss; its deletion impairs invasion, slows proliferation, and prolongs survival in murine models of glioblastoma. Myosin 10 deletion also enhances tumor dependency on the DNA damage and the metabolic stress responses and induces synthetic lethality when combined with inhibitors of these processes. Our results thus demonstrate that targeting myosin 10 is active against glioblastoma by itself, synergizes with other clinically available therapeutics, may have acceptable side effects in normal tissues, and has potential as a heretofore unexplored therapeutic approach for this disease.Graphical AbstractDisplay OmittedHighlights•Myosin 10 provides glioblastoma cells with directional flexibility•Myosin 10 drives glioblastoma growth by stimulating integrin-dependent signaling•Myosin 10 deletion induces DNA damage and sensitizes tumors to PARP inhibitors•Targeting myosin 10 prolongs survival in mouse models of glioblastomaCell Biology; Cancer
